Non-Hodgkin ‘s lymphoma, and Hodgkin’s disease, which a Hodgkin’s lymphoma, a variety of cancers immune system, immune system, such as DLBCL, mantle cell lymphoma, follicular lymphoma and related . Up to 60 percent of patients with aggressive types of NHL, including DLBCL, may be cured with appropriate therapy . However, NHL patients of relapse of relapse after initial therapy and no treatments are currently available to reduce this risk .
The UW will receive $ 25 million to the Northwest Genomics Center to start one of the two sequencing centers for the project. The second center is sequencing at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts is.The study is carried out at Charing Cross Hospital in west London. Volunteers will be for her time that will be paid for the study. Volunteers between 50 and 70, age, participate in not breathing difficulties and age, should be call 020 8846 1234 external. About their interest.